摘要
Abstract
Objective To study therapeutic effect of low molecular weight calciparine combined with Fufang Shenyan pill on primary nephrotic syndrome (PNS ) .Methods 100 patients with PNS ,receiving treatment in this hospital from Sep .2006 to Sep .2012 ,were enrolled and divided into control group ,receiving routine therapy ,and experiment group ,receiving combined therapy of low molecular weight calciparine and Fufang Shenyan pill other than routine therapy .One month after therapy ,the effective rate ,significant efficiency rate ,inefficient rate and changes of biochemical indexes were analyzed .Results The effective rate in experiment group was 64 .00% ,higher than the 50 .00% of control group ,and the significant efficiency rate was 34 .00% ,lower than the 44 .00% of control group (P<0 .05) .Levels of cholesterol ,urine protein ,triglyceride and albumin recovered to normal level more rap-idly in experiment group than control group .Conclusion Combined therapy of low molecular weight calciparine and Fufang Shenyan pill could be effective for the therapy of PNS with high clinical cure rate ,which might be worthy of clinical promotion .关键词
低分子肝素钙/复方肾炎片/原发性肾病综合征/生化指标Key words
low molecular weight calciparine/Fufang Shenyan pill/primary nephrotic syndrome/bio-chemical indexes
